Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.55 |
| ▸ | HPGD | P15428 | 2/20 | 0.55 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.55 |
| ▸ | ALDH5A1 | P51649 | 1/20 | 0.55 |
| ▸ | ABAT | P80404 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.55 |
| ▸ | ERN1 | O75460 | 5/20 | 0.53 |
| ▸ | PTGS1 | P23219 | 4/20 | 0.51 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.51 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | AOX1 | Q06278 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.49 |
| ▸ | CYP2B6 | P20813 | 2/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29952164 | 1.00 | EGFR (0.58) | EGFRALDH1A1HPGDTRIM24ALDH5A1 | |
| Syringaldehyde SCHEMBL150376 | 0.88 | ALDH1A1 (0.62) | ALDH1A1HPGDTRIM24ALDH5A1ABAT | |
| Syringaldehyde SCHEMBL30119623 | 0.88 | ALDH1A1 (0.62) | ALDH1A1HPGDTRIM24ALDH5A1ABAT | |
| Syringaldehyde SCHEMBL2110596 | 0.88 | ALDH1A1 (0.62) | ALDH1A1HPGDTRIM24ALDH5A1ABAT | |
| Syringaldehyde SCHEMBL11013780 | 0.86 | ALDH1A1 (0.60) | ALDH1A1HPGDTRIM24ALDH5A1ABAT | |
| Syringaldehyde SCHEMBL28299840 | 0.86 | ALDH1A1 (0.60) | ALDH1A1HPGDTRIM24ALDH5A1ABAT | |
| Syringaldehyde SCHEMBL27352107 | 0.86 | ALDH1A1 (0.60) | ALDH1A1HPGDTRIM24ALDH5A1ABAT | |
| Syringaldehyde SCHEMBL29724072 | 0.86 | ALDH1A1 (0.60) | ALDH1A1HPGDTRIM24ALDH5A1ABAT | |
| Syringaldehyde SCHEMBL28642631 | 0.86 | ALDH1A1 (0.60) | ALDH1A1HPGDTRIM24ALDH5A1ABAT | |
| SCHEMBL28901029 | 0.85 | ERN1 (0.69) | EGFRALDH1A1HPGDTRIM24ALDH5A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 120 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112079697-A | Preparation method of 5-methyl vanillin | 上海应用技术大学 | 2020-12-15 | — | — | CN | claimed |
| CN-111707754-A | Method for measuring guaiacol, ortho-vanillin, 5-methyl vanillin and 5-aldehyde vanillin in vanillin | 上海应用技术大学 | 2020-09-25 | — | — | CN | claimed |
| CN-104203891-B | Process for producing alkoxy-hydroxybenzaldehydes substantially free of alkyl-alkoxy-hydroxybenzaldehydes | 罗地亚运作公司 | 2019-03-15 | — | — | CN | claimed |
| EP-2760815-B1 | METHOD FOR PRODUCING ALKOXY-HYDROXYBENZALDEHYDE THAT IS SUBSTANTIALLY FREE OF ALKYL-ALKOXY-HYDROXYBENZALDEHYDE | RHODIA OPERATIONS (FR) | 2016-08-24 | — | — | EP | claimed |
| US-9284247-B2 | Method for producing alkoxy-hydroxybenzaldehyde that is substantially free of alkyl-alkoxy-hydroxybenzaldehyde | RHODIA OPERATIONS (FR) | 2016-03-15 | — | — | US | claimed |
| US-20150203428-A1 | Method for producing alkoxy-hydroxybenzaldehyde that is substantially free of alkyl-alkoxy-hydroxybenzaldehyde | SPECIALTY OPERATIONS FRANCE (FR) | 2015-07-23 | — | — | US | claimed |
| EP-2760815-A1 | METHOD FOR PRODUCING ALKOXY-HYDROXYBENZALDEHYDE THAT IS SUBSTANTIALLY FREE OF ALKYL-ALKOXY-HYDROXYBENZALDEHYDE | RHODIA OPERATIONS (FR) | 2014-08-06 | — | — | EP | claimed |
| WO-2014016145-A1 | METHOD FOR PRODUCING ALKOXY-HYDROXYBENZALDEHYDE THAT IS SUBSTANTIALLY FREE OF ALKYL-ALKOXY-HYDROXYBENZALDEHYDE | RHODIA OPERATIONS (FR) | 2014-01-30 | — | — | WO | claimed |
| WO-2024135708-A1 | METHOD FOR PRODUCING COMPOUND, POLYMER, COMPOSITION, AND PATTERN FORMATION METHOD | 三菱瓦斯化学株式会社 | 2024-06-27 | — | — | WO | disclosed |
| US-11814597-B2 | Process for the production of oxidized wood products | ORGANOFUEL SWEDEN AB (SE) | 2023-11-14 | — | — | US | disclosed |
| US-11654198-B2 | Application of combination of polyethylene glycol and local anesthetic in non-narcotic analgesia | JENKEM TECHNOLOGY CO., LTD. (TIANJIN) (CN) | 2023-05-23 | — | — | US | disclosed |
| US-11654198-B2 | Application of combination of polyethylene glycol and local anesthetic in non-narcotic analgesia | JENKEM TECHNOLOGY CO., LTD. (TIANJIN) (CN) | 2023-05-23 | — | — | US | disclosed |
| US-11584727-B2 | 2-thioxothiazolidin-4-one derivatives active as transthyretin ligands and uses thereof | BSIM THERAPEUTICS, S.A. (PT) | 2023-02-21 | — | — | US | disclosed |
| US-11584727-B2 | 2-thioxothiazolidin-4-one derivatives active as transthyretin ligands and uses thereof | BSIM THERAPEUTICS, S.A. (PT) | 2023-02-21 | — | — | US | disclosed |
| WO-1997002037-A1 | COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | SYMPHAR S.A. (CH) | 1997-01-23 | — | — | WO | disclosed |
| EP-0334119-B1 | COMPOUNDS FOR INHIBITING THE BIOSYNTHESIS OF LIPOXYGENASE-DERIVED METABOLITES OF ARACHIDONIC ACID | BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) | 1993-06-16 | — | — | EP | disclosed |
| EP-0334119-A1 | Compounds for inhibiting the biosynthesis of lipoxygenase-derived metabolites of arachidonic acid | BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) | 1989-09-27 | — | — | EP | disclosed |
| US-4157286-A | Production of 1,2-bis(hydroxyphenyl)ethane-1,2-diols by electrolytic reduction | MONSANTO COMPANY (US) | 1979-06-05 | — | — | US | disclosed |
| US-4133729-A | Production of 1,2-bis(hydroxy-phenyl)ethane-1,2-diols by electrolytic reduction | MONSANTO COMPANY (US) | 1979-01-09 | — | — | US | disclosed |
| US-4087336-A | Electrolytic reductive coupling of hydroxybenzaldehydes | MONSANTO COMPANY (US) | 1978-05-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11814597-B2 | Process for the production of oxidized wood products | NOX4, NOX5, AOC2 | EGFR 4579/4885ALDH1A1 73/4885HPGD 106/4885 |
| US-20150203428-A1 | Method for producing alkoxy-hydroxybenzaldehyde that is substantially free of alkyl-alkoxy-hydroxybenzaldehyde | HPD, APEH, HMBS | EGFR 3986/4885ALDH1A1 29/4885HPGD 227/4885 |
| US-11584727-B2 | 2-thioxothiazolidin-4-one derivatives active as transthyretin ligands and uses thereof | TTR, TTPA, MTPN | EGFR 4120/4885ALDH1A1 2165/4885HPGD 3647/4885 |
| US-11654198-B2 | Application of combination of polyethylene glycol and local anesthetic in non-narcotic analgesia | OPRL1, OPRK1, OPRM1 | EGFR 999/4885ALDH1A1 689/4885HPGD 558/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.